Restoring FAS expression by reversing FAS promoter methylation: A novel approach to CTCL therapy

被引:0
|
作者
Wu, J. [1 ,2 ]
Wood, G. S. [1 ,2 ]
机构
[1] Univ Wisconsin, Madison, WI USA
[2] VAMC, Madison, WI USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
173
引用
收藏
页码:S29 / S29
页数:1
相关论文
共 50 条
  • [41] A novel cytoplasmic motif regulates Fas ligand production and cell surface expression
    Xiao, S
    Judo, S
    Sung, SSJ
    Ju, ST
    FASEB JOURNAL, 2004, 18 (04): : A46 - A46
  • [42] (-)-Epigallocatechin-3-gallate (EGCG) modulates FAS (APO-1/CD95) expression in CTCL derived lines
    Nihal, M.
    Wu, J.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 44 - 44
  • [43] Analysis of methylation and mRNA expression status of FADD and FAS genes in patients with oral squamous cell carcinoma
    Saberi, Eshaghali
    Kordi-Tamandani, Dor-Mohammad
    Jamali, Sara
    Rigi-Ladez, Mohammad-Ayoub
    Augend, Arsalan
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2014, 19 (06): : E562 - E568
  • [44] Adenoviral vector-mediated gene therapy in the mouse lung: No role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells
    Chirmule, N
    Moffett, J
    Dhagat, P
    Tazelaar, J
    Wilson, JM
    HUMAN GENE THERAPY, 1999, 10 (17) : 2839 - 2846
  • [45] FAS-ligand expression is not required for pathogenesis in a novel mouse model of colitis.
    Simpson, SJ
    Hollander, GA
    Mizoguchi, E
    Bhan, AK
    Wang, B
    Shah, SA
    Terhorst, C
    GASTROENTEROLOGY, 1996, 110 (04) : A1015 - A1015
  • [46] Gene therapy with soluble Fas: A novel anti-apoptosis strategy for transplant arteriosclerosis
    Goldschmidt-Clermont, PJ
    Wang, T
    Stevenson, SC
    Dong, C
    Moldovan, MI
    Herderich, EE
    TRANSPLANTATION, 1999, 67 (09) : S571 - S571
  • [47] Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
    Chen Zhang
    Xinyin Liu
    Shidai Jin
    Yi Chen
    Renhua Guo
    Molecular Cancer, 21
  • [48] Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
    Zhang, Chen
    Liu, Xinyin
    Jin, Shidai
    Chen, Yi
    Guo, Renhua
    MOLECULAR CANCER, 2022, 21 (01)
  • [49] Alteration of the expression of Bcl-2, Bcl-x, bax, fas, and fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy
    Yamamoto, T
    Nishioka, K
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2003, 16 (01): : 50 - 58
  • [50] Requirement of distal and proximal promoter regions for in vivo levels of fatty acid synthase (FAS) gene expression.
    Rufo, C
    Nakamura, MT
    Clarke, SD
    FASEB JOURNAL, 2000, 14 (04): : A209 - A209